131 related articles for article (PubMed ID: 11051226)
21. EWS-FLI1 inhibits TNFalpha-induced NFkappaB-dependent transcription in Ewing sarcoma cells.
Lagirand-Cantaloube J; Laud K; Lilienbaum A; Tirode F; Delattre O; Auclair C; Kryszke MH
Biochem Biophys Res Commun; 2010 Sep; 399(4):705-10. PubMed ID: 20691659
[TBL] [Abstract][Full Text] [Related]
22. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.
Deneen B; Denny CT
Oncogene; 2001 Oct; 20(46):6731-41. PubMed ID: 11709708
[TBL] [Abstract][Full Text] [Related]
23. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood.
Sorensen PH; Liu XF; Delattre O; Rowland JM; Biggs CA; Thomas G; Triche TJ
Diagn Mol Pathol; 1993 Sep; 2(3):147-57. PubMed ID: 7506981
[TBL] [Abstract][Full Text] [Related]
24. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
[TBL] [Abstract][Full Text] [Related]
25. Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.
Petermann R; Mossier BM; Aryee DN; Khazak V; Golemis EA; Kovar H
Oncogene; 1998 Aug; 17(5):603-10. PubMed ID: 9704926
[TBL] [Abstract][Full Text] [Related]
26. [Detection of EWS-/FLI-1 gene fusion transcripts by RT-PCR as a tool in the diagnosis of tumors of the Ewing sarcoma group].
Dockhorn-Dworniczak B; Schäfer KL; Dantcheva R; Blasius S; van Valen F; Burdach S; Winkelmann W; Jürgens J; Böcker W
Verh Dtsch Ges Pathol; 1994; 78():214-9. PubMed ID: 7533989
[TBL] [Abstract][Full Text] [Related]
27. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
[TBL] [Abstract][Full Text] [Related]
28. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
29. Chimeric EWS-FLI1 transcript in a Ewing cell line with a complex t(11;22;14) translocation.
Bonin G; Scamps C; Turc-Carel C; Lipinski M
Cancer Res; 1993 Aug; 53(16):3655-7. PubMed ID: 8339272
[TBL] [Abstract][Full Text] [Related]
30. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
[TBL] [Abstract][Full Text] [Related]
31. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines.
Rorie CJ; Weissman BE
Cancer Res; 2004 Oct; 64(20):7288-95. PubMed ID: 15492248
[TBL] [Abstract][Full Text] [Related]
32. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
33. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
Coles EG; Lawlor ER; Bronner-Fraser M
Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
[TBL] [Abstract][Full Text] [Related]
34. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
[TBL] [Abstract][Full Text] [Related]
35. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
[TBL] [Abstract][Full Text] [Related]
36. Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.
Sugimoto T; Bartholomeusz C; Tari AM; Ueno NT
Breast Cancer Res; 2007; 9(4):R41. PubMed ID: 17612393
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression.
Dauphinot L; De Oliveira C; Melot T; Sevenet N; Thomas V; Weissman BE; Delattre O
Oncogene; 2001 May; 20(25):3258-65. PubMed ID: 11423975
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.
Chansky HA; Hu M; Hickstein DD; Yang L
Cancer Res; 2001 May; 61(9):3586-90. PubMed ID: 11325824
[TBL] [Abstract][Full Text] [Related]
39. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H
Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527
[TBL] [Abstract][Full Text] [Related]
40. Cryptic exons as a source of increased diversity of Ewing tumor-associated EWS-FLI1 chimeric products.
Kovar H; Jugovic D; Melot T; Zoubek A; Lenoir G; Fink FM; Philip I; Turc-Carel C; Thomas G; Zucman-Rossi J
Genomics; 1999 Sep; 60(3):371-4. PubMed ID: 10493837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
